Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , , , , , , , , |
Tipo de documento: | preprint |
Idioma: | eng |
Título da fonte: | SciELO Preprints |
Texto Completo: | https://preprints.scielo.org/index.php/scielo/preprint/view/348 |
Resumo: | CONTEXT AND OBJECTIVE: Coronavirus disease 2019 (COVID-19) has emerged in China in December 2019 and rapidly spread. Although extraordinary efforts have been made on research regarding pharmacological interventions, none have proven effective. This is the protocol for a rapid living systematic review that aims to compare the effectiveness and safety of different pharmacological interventions for the treatment of COVID-19. METHODS: rapid living systematic review methodology with Network Meta-Analysis following the recommendations of Cochrane Handbook. We will include randomized controlled trials (RCT) and quasi-RCTs that evaluate single and/or combined pharmacological interventions at any dose for the treatment of COVID-19. We will search Medline via PubMed, Embase via Elsevier, Cochrane Library - Cochrane Central Register of Controlled Trials (CENTRAL), Portal Regional BVS - LILACS, Scopus and WebofScience to identify potentially eligible studies. No language restrictions will be used in the selection. We will perform the critical appraisal of included studies with the Risk of Bias tool and the certainty of evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE). |
id |
SCI-1_e14e34c97608d48ed7a1efa1e85aa4e3 |
---|---|
oai_identifier_str |
oai:ops.preprints.scielo.org:preprint/348 |
network_acronym_str |
SCI-1 |
network_name_str |
SciELO Preprints |
repository_id_str |
|
spelling |
Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysisNetwork Meta-analysisdrug therapycoronavirus infectionssystematic reviewCONTEXT AND OBJECTIVE: Coronavirus disease 2019 (COVID-19) has emerged in China in December 2019 and rapidly spread. Although extraordinary efforts have been made on research regarding pharmacological interventions, none have proven effective. This is the protocol for a rapid living systematic review that aims to compare the effectiveness and safety of different pharmacological interventions for the treatment of COVID-19. METHODS: rapid living systematic review methodology with Network Meta-Analysis following the recommendations of Cochrane Handbook. We will include randomized controlled trials (RCT) and quasi-RCTs that evaluate single and/or combined pharmacological interventions at any dose for the treatment of COVID-19. We will search Medline via PubMed, Embase via Elsevier, Cochrane Library - Cochrane Central Register of Controlled Trials (CENTRAL), Portal Regional BVS - LILACS, Scopus and WebofScience to identify potentially eligible studies. No language restrictions will be used in the selection. We will perform the critical appraisal of included studies with the Risk of Bias tool and the certainty of evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE).SciELO PreprintsSciELO PreprintsSciELO Preprints2020-05-06info:eu-repo/semantics/preprintinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://preprints.scielo.org/index.php/scielo/preprint/view/34810.1590/SciELOPreprints.348enghttps://preprints.scielo.org/index.php/scielo/article/view/348/437Copyright (c) 2020 Maria Eduarda dos Santos Puga, Ana Carolina Pereira Nunes Pinto, Aline Pereira da Rocha, Keilla Martins Milby, César Ramos Rocha-Filho, Felipe Sebastião de Assis Reis, Nelson Carvas Junior, Vinicius Tassoni Civile, Rodolfo Rodrigo Pereira Santos, Giulia Fernandes Moça Trevisani, Laura Jantsch Ferla, Gabriel Sodré Ramalho, Maria Eduarda dos Santos Puga, Virgínia Fernandes Moça Trevisani, Alvaro Nagib Atallahhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessPuga, Maria Eduarda dos SantosPinto, Ana Carolina Pereira NunesRocha, Aline Pereira daMilby, Keilla MartinsRocha-Filho, César RamosReis, Felipe Sebastião de AssisCarvas Junior, NelsonCivile, Vinicius TassoniSantos, Rodolfo Rodrigo PereiraTrevisani, Giulia Fernandes MoçaFerla, Laura JantschRamalho, Gabriel SodréPuga, Maria Eduarda dos SantosTrevisani, Virgínia Fernandes MoçaAtallah, Alvaro Nagibreponame:SciELO Preprintsinstname:SciELOinstacron:SCI2020-05-06T02:16:09Zoai:ops.preprints.scielo.org:preprint/348Servidor de preprintshttps://preprints.scielo.org/index.php/scieloONGhttps://preprints.scielo.org/index.php/scielo/oaiscielo.submission@scielo.orgopendoar:2020-05-06T02:16:09SciELO Preprints - SciELOfalse |
dc.title.none.fl_str_mv |
Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis |
title |
Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis |
spellingShingle |
Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis Puga, Maria Eduarda dos Santos Network Meta-analysis drug therapy coronavirus infections systematic review |
title_short |
Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis |
title_full |
Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis |
title_fullStr |
Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis |
title_full_unstemmed |
Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis |
title_sort |
Pharmacological interventions for COVID-19: Protocol for a Rapid Living Systematic Review with network meta-analysis |
author |
Puga, Maria Eduarda dos Santos |
author_facet |
Puga, Maria Eduarda dos Santos Pinto, Ana Carolina Pereira Nunes Rocha, Aline Pereira da Milby, Keilla Martins Rocha-Filho, César Ramos Reis, Felipe Sebastião de Assis Carvas Junior, Nelson Civile, Vinicius Tassoni Santos, Rodolfo Rodrigo Pereira Trevisani, Giulia Fernandes Moça Ferla, Laura Jantsch Ramalho, Gabriel Sodré Trevisani, Virgínia Fernandes Moça Atallah, Alvaro Nagib |
author_role |
author |
author2 |
Pinto, Ana Carolina Pereira Nunes Rocha, Aline Pereira da Milby, Keilla Martins Rocha-Filho, César Ramos Reis, Felipe Sebastião de Assis Carvas Junior, Nelson Civile, Vinicius Tassoni Santos, Rodolfo Rodrigo Pereira Trevisani, Giulia Fernandes Moça Ferla, Laura Jantsch Ramalho, Gabriel Sodré Trevisani, Virgínia Fernandes Moça Atallah, Alvaro Nagib |
author2_role |
author author author author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Puga, Maria Eduarda dos Santos Pinto, Ana Carolina Pereira Nunes Rocha, Aline Pereira da Milby, Keilla Martins Rocha-Filho, César Ramos Reis, Felipe Sebastião de Assis Carvas Junior, Nelson Civile, Vinicius Tassoni Santos, Rodolfo Rodrigo Pereira Trevisani, Giulia Fernandes Moça Ferla, Laura Jantsch Ramalho, Gabriel Sodré Puga, Maria Eduarda dos Santos Trevisani, Virgínia Fernandes Moça Atallah, Alvaro Nagib |
dc.subject.por.fl_str_mv |
Network Meta-analysis drug therapy coronavirus infections systematic review |
topic |
Network Meta-analysis drug therapy coronavirus infections systematic review |
description |
CONTEXT AND OBJECTIVE: Coronavirus disease 2019 (COVID-19) has emerged in China in December 2019 and rapidly spread. Although extraordinary efforts have been made on research regarding pharmacological interventions, none have proven effective. This is the protocol for a rapid living systematic review that aims to compare the effectiveness and safety of different pharmacological interventions for the treatment of COVID-19. METHODS: rapid living systematic review methodology with Network Meta-Analysis following the recommendations of Cochrane Handbook. We will include randomized controlled trials (RCT) and quasi-RCTs that evaluate single and/or combined pharmacological interventions at any dose for the treatment of COVID-19. We will search Medline via PubMed, Embase via Elsevier, Cochrane Library - Cochrane Central Register of Controlled Trials (CENTRAL), Portal Regional BVS - LILACS, Scopus and WebofScience to identify potentially eligible studies. No language restrictions will be used in the selection. We will perform the critical appraisal of included studies with the Risk of Bias tool and the certainty of evidence will be evaluated using the Grading of Recommendations Assessment, Development and Evaluation (GRADE). |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-05-06 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/preprint info:eu-repo/semantics/publishedVersion |
format |
preprint |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://preprints.scielo.org/index.php/scielo/preprint/view/348 10.1590/SciELOPreprints.348 |
url |
https://preprints.scielo.org/index.php/scielo/preprint/view/348 |
identifier_str_mv |
10.1590/SciELOPreprints.348 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://preprints.scielo.org/index.php/scielo/article/view/348/437 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
SciELO Preprints SciELO Preprints SciELO Preprints |
publisher.none.fl_str_mv |
SciELO Preprints SciELO Preprints SciELO Preprints |
dc.source.none.fl_str_mv |
reponame:SciELO Preprints instname:SciELO instacron:SCI |
instname_str |
SciELO |
instacron_str |
SCI |
institution |
SCI |
reponame_str |
SciELO Preprints |
collection |
SciELO Preprints |
repository.name.fl_str_mv |
SciELO Preprints - SciELO |
repository.mail.fl_str_mv |
scielo.submission@scielo.org |
_version_ |
1797047817263382528 |